Cite
HARVARD Citation
Wang, L. et al. (2018). Dual silencing of EGFR and HER2 enhances the sensitivity of gastric cancer cells to gefitinib. Molecular carcinogenesis. 57 (8), pp. 1008-1016. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Wang, L. et al. (2018). Dual silencing of EGFR and HER2 enhances the sensitivity of gastric cancer cells to gefitinib. Molecular carcinogenesis. 57 (8), pp. 1008-1016. [Online].